Grant: Engage Grants Program
Simon Fraser University
$25,000.00
Design and engineering of novel cell permeable proteins that can enter human cells and regulate HIV genome transcription.
EF 2013-14
Résumé
iProgen Biotech and Dr. Mark Brockman will collaborate on the engineering and development of novel cellpermeable proteins that can potentially regulate viral genome transcription. Such technology would prove to bevery useful in treating various chronic latent viral infections such as HIV, Hepatitis and Herpes. iProgen willapply its expertise and advanced knowledge in intracellular protein delivery technology to design, engineer andproduce cell permeable proteins with commercial potential. Dr. Brockman will provide expertise in HIVvirology and pathogenesis and his laboratory will study the cell permeable proteins' in vitro activity and abilityto enhance latent HIV viral transcription.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
448510-2013
Name nom
Brockman, MarkAlan
Department département
Health Sciences, Faculty of
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5305
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Protein manipulation and expression
Research subject fr
Expression et recombinaison protéiques
Partie
1
Nb partie
1
Application title
Design and engineering of novel cell permeable proteins that can enter human cells and regulate HIV genome transcription.
Keyword
NSERC
Application summary
iProgen Biotech and Dr. Mark Brockman will collaborate on the engineering and development of novel cellpermeable proteins that can potentially regulate viral genome transcription. Such technology would prove to bevery useful in treating various chronic latent viral infections such as HIV, Hepatitis and Herpes. iProgen willapply its expertise and advanced knowledge in intracellular protein delivery technology to design, engineer andproduce cell permeable proteins with commercial potential. Dr. Brockman will provide expertise in HIVvirology and pathogenesis and his laboratory will study the cell permeable proteins' in vitro activity and abilityto enhance latent HIV viral transcription.